Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis
Jéssica Diniz Pereira, Jéssica Abdo Gonçalves Tosatti, Ricardo Simões, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110709-110709
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 18
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO
Sara Pizzamiglio, Chiara Maura Ciniselli, Evandro de Azambuja, et al.
Breast Cancer Research and Treatment (2024) Vol. 206, Iss. 2, pp. 285-294
Open Access | Times Cited: 4
MicroRNA as a promising molecular biomarker in the diagnosis of breast cancer
Felipe Silva de Miranda, José Slaibi-Filho, Gabriel Calasans dos Santos, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 4
Predicting doxorubicin-induced cardiotoxicity in breast cancer: leveraging machine learning with synthetic data
Daniella Castro Araújo, Ricardo Santos Simões, Adriano de Paula Sabino, et al.
Medical & Biological Engineering & Computing (2025)
Closed Access
Long-term impact of anthracycline in early-stage breast cancer, bridging of MiRNAs profiler for early cardiotoxicity
Nattaya Poovorawan, Thiti Susiriwatananont, Chinachote Teerapakpinyo, et al.
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access
MicroRNA-1: Diverse role of a small player in multiple cancers
Parvez Κhan, Nivetha Sarah Ebenezer, Jawed A. Siddiqui, et al.
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 114-126
Open Access | Times Cited: 23
MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
Ippei Kawano, Michaela Adamcová
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods
Ziyu Kuang, Miao Kong, Ningzhe Yan, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 679-701
Open Access | Times Cited: 3
MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats
Rafael Sánchez-Sánchez, Ignacio Reinal, Esteban Peiró-Molina, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1955-1955
Open Access | Times Cited: 13
Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model
Michaela Adamcová, Helena Párová, Olga Lenčová-Popelová, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 2
Anthracycline-Induced Cardiomyopathy in Cancer Survivors: Management and Long-Term Implications
Seyed Abolfazl Mohsenizadeh, Mohsen Rajaeinejad, Mehran Khoshfetrat, et al.
Advances in experimental medicine and biology (2024)
Closed Access | Times Cited: 2
Interleukin-10 Levels are Associated with Doxorubicin-Related Cardiotoxicity in Breast Cancer Patients in a One-Year Follow-Up Study
Michelle Teodoro Alves, Ricardo Simões, Rodrigo Mendonça Cardoso Pestana, et al.
Immunological Investigations (2021) Vol. 51, Iss. 4, pp. 883-898
Closed Access | Times Cited: 14
MiR‐494‐3p aggravates pirarubicin‐induced cardiomyocyte injury by regulating MDM4/p53 signaling pathway
Peng Huang, Yibing Zhang, Fengjun Wang, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 10, pp. 2499-2508
Open Access | Times Cited: 5
Effects of miR-143 regulation on cardiomyocytes apoptosis in doxorubicin cardiotoxicity based on integrated bioinformatics analysis
Chi Zhou, Yayuan Yang, Ling Hu, et al.
Toxicology in Vitro (2023) Vol. 93, pp. 105662-105662
Closed Access | Times Cited: 5
Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach
Yifei Rao, Yu Wang, Zhijian Lin, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers
Isabel Moscoso, Moisés Rodríguez‐Mañero, María Cebro-Márquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11910-11910
Open Access | Times Cited: 1
microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation
Michelle Teodoro Alves, Izabela Mamede, Angélica Navarro de Oliveira, et al.
Cardiovascular Toxicology (2022) Vol. 22, Iss. 7, pp. 655-662
Closed Access | Times Cited: 7
The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
Zihan Si, Yan Zhong, Sixian Lao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Biomarkers of chemotherapy-induced cardiotoxicity: toward precision prevention using extracellular vesicles
Brian B. Silver, Anna Kreutz, Madeleine Weick, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
Liuying Chen, Yizhou Xu
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 9
Biomarker Determinants of Early Anthracycline-Induced Left Ventricular Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis
Stavroula Kastora, Tiberiu A. Pana, Yusuf Sarwar, et al.
Molecular Diagnosis & Therapy (2022) Vol. 26, Iss. 4, pp. 369-382
Closed Access | Times Cited: 6
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review
Roberto Rosenfeld, Silvia Riondino, Vincenzo Formica, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1059-1059
Open Access | Times Cited: 6
Long Noncoding RNA TTC39A-AS1 Promotes Breast Cancer Tumorigenicity by Sponging MicroRNA-483-3p and Thereby Upregulating MTA2
Zhaohui Zhou, Ping Yang, Binming Zhang, et al.
Pharmacology (2021) Vol. 106, Iss. 11-12, pp. 573-587
Closed Access | Times Cited: 5
Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers
Dongqing Chen, C. Kelly, Tatt Jhong Haw, et al.
Current Heart Failure Reports (2021) Vol. 18, Iss. 6, pp. 362-377
Closed Access | Times Cited: 5
MicroRNAs as Potential Biomarkers for Exercise-Based Cancer Rehabilitation in Cancer Survivors
Yanping Jiang, Kulsoom Ghias, Sanjeev Gupta, et al.
Life (2021) Vol. 11, Iss. 12, pp. 1439-1439
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top